Reduce Cardiovascular Risk With VASCEPA® …...References: 1. Bhatt DI-. Steg PG. Miller M, et al;...

3
Reduce Cardiovascular Risk With VASCEPA® (icosapent ethyl): Evidence From REDUCE-IT™ Guest Speaker: Joyce L. Ross, MSN, RN.C., CRNP, CS, FNLA, FPCNA Certified Clinical Lipid Specialist Consultative Education Specialist, Cardiovascular Risk Intervention University of Pennsylvania Health System Philadelphia, PA West Chester, Pennsylvania Marriott River Center 10 West Rivercenter Boulevard Covington, KY 41011 (859) 392-3721 Wednesday, April 24, 2019 11:00 AM Hosted by: Kathleen Bucher (859) 653-8629 Please register at: https://amarin.phoenixgrpmeetings.com Click on “Register for a Meeting.” Enter code AMA-VAS-5995

Transcript of Reduce Cardiovascular Risk With VASCEPA® …...References: 1. Bhatt DI-. Steg PG. Miller M, et al;...

Page 1: Reduce Cardiovascular Risk With VASCEPA® …...References: 1. Bhatt DI-. Steg PG. Miller M, et al; for the REDUCE-IT Investigators. Cardiovascular risk reduction with icosapent ethyl

Reduce Cardiovascular Risk With VASCEPA® (icosapent ethyl): Evidence From REDUCE-IT™

Guest Speaker: Joyce L. Ross, MSN, RN.C., CRNP, CS, FNLA, FPCNA

Certified Clinical Lipid Specialist Consultative Education Specialist, Cardiovascular Risk Intervention

University of Pennsylvania Health System Philadelphia, PA West Chester, Pennsylvania

Marriott River Center

10 West Rivercenter Boulevard Covington, KY 41011

(859) 392-3721

Wednesday, April 24, 2019 11:00 AM

Hosted by: Kathleen Bucher

(859) 653-8629 Please register at: https://amarin.phoenixgrpmeetings.com

Click on “Register for a Meeting.” Enter code AMA-VAS-5995

https://amarin.phoenixgrpmeetings.com/
https://amarin.phoenixgrpmeetings.com/
Page 2: Reduce Cardiovascular Risk With VASCEPA® …...References: 1. Bhatt DI-. Steg PG. Miller M, et al; for the REDUCE-IT Investigators. Cardiovascular risk reduction with icosapent ethyl
Page 3: Reduce Cardiovascular Risk With VASCEPA® …...References: 1. Bhatt DI-. Steg PG. Miller M, et al; for the REDUCE-IT Investigators. Cardiovascular risk reduction with icosapent ethyl

CARDIOVASCULAR PHYSIOLOGY. CARDIOVASCULAR PHYSIOLOGY LECTURES.

CARDIOVASCULAR PHYSIOLOGY. CARDIOVASCULAR PHYSIOLOGY LECTURES.

SEMIOLOGIA CARDIOVASCULAR. SISTEMA CARDIOVASCULAR.

SEMIOLOGIA CARDIOVASCULAR. SISTEMA CARDIOVASCULAR.

HLS Therapeutics Announces Vascepa® (icosapent ethyl ... · rights to Vascepa for the Canadian market. VASCEPA IS NOT APPROVED IN CANADA. ABOUT HLS THERAPEUTICS INC. Formed in 2015,

HLS Therapeutics Announces Vascepa® (icosapent ethyl ... · rights to Vascepa for the Canadian market. VASCEPA IS NOT APPROVED IN CANADA. ABOUT HLS THERAPEUTICS INC. Formed in 2015,

VASCEPA COVID-19 CardioLink-9: First Human Trial of a ...

VASCEPA COVID-19 CardioLink-9: First Human Trial of a ...

$9 VASCEPA · Bác sĩ của quý vị có thể làm các xét nghiệm máu để kiểm tra mức triglyceride và các loại mỡ khác trong khi quý vị dùng VASCEPA. Các

$9 VASCEPA · Bác sĩ của quý vị có thể làm các xét nghiệm máu để kiểm tra mức triglyceride và các loại mỡ khác trong khi quý vị dùng VASCEPA. Các

2014 Asia-Pacific cardiovascular symposium Managing ... Asia-Pacific cardiovascular symposium Managing cardiovascular risk ... 2014 Asia-Pacific cardiovascular symposium “Managing

2014 Asia-Pacific cardiovascular symposium Managing ... Asia-Pacific cardiovascular symposium Managing cardiovascular risk ... 2014 Asia-Pacific cardiovascular symposium “Managing

Your PreventiveRxSM Drug List: Expanded Plan€¦ · Liptruzet Livalo lovastatin Lovaza niacin ER Niacor Niaspan pravastatin Prevalite Simcor simvastatin Triglide Vascepa Vytorin

Your PreventiveRxSM Drug List: Expanded Plan€¦ · Liptruzet Livalo lovastatin Lovaza niacin ER Niacor Niaspan pravastatin Prevalite Simcor simvastatin Triglide Vascepa Vytorin

Cardiovascular Structure & Function Cardiovascular Structure & Function.

Cardiovascular Structure & Function Cardiovascular Structure & Function.

Cardiovascular System II - aplsonline.com · Cardiovascular System II 2 Initial assessment: ... System II Cardiovascular System II11 Case Development ... Cardiovascular System II12

Cardiovascular System II - aplsonline.com · Cardiovascular System II 2 Initial assessment: ... System II Cardiovascular System II11 Case Development ... Cardiovascular System II12

How Does Vascepa Work? Potential Mechanisms of Action for ...

How Does Vascepa Work? Potential Mechanisms of Action for ...

iti Ingles). Ania ti VASCEPA? VASCEPA...Ngem no nalipatam ti nagtomar iti VASCEPA iti maysa nga aldaw, saan mo a dobdoblien ti dosis mo inton agtomar ka. • Mabalin nga ibilin ti

iti Ingles). Ania ti VASCEPA? VASCEPA...Ngem no nalipatam ti nagtomar iti VASCEPA iti maysa nga aldaw, saan mo a dobdoblien ti dosis mo inton agtomar ka. • Mabalin nga ibilin ti

(icosapent ethyl) Retail Fact Sheet for VASCEPA• Adverse events may be reported by calling 1-855-VASCEPA or the FDA at 1-800-FDA-1088 • Patients receiving VASCEPA and concomitant

(icosapent ethyl) Retail Fact Sheet for VASCEPA• Adverse events may be reported by calling 1-855-VASCEPA or the FDA at 1-800-FDA-1088 • Patients receiving VASCEPA and concomitant

Trying to lower very high triglycerides? The choice is clear. · 10 PATIENT INFORMATION VASCEPA® (pronounced vas-EE-puh) (icosapent ethyl) Capsules WHAT IS VASCEPA? VASCEPA is a

Trying to lower very high triglycerides? The choice is clear. · 10 PATIENT INFORMATION VASCEPA® (pronounced vas-EE-puh) (icosapent ethyl) Capsules WHAT IS VASCEPA? VASCEPA is a

Cardiovascular PhysiologyCardiovascular Physiologyuserhome.brooklyn.cuny.edu/jsiegler/Lecture 10... · 2005-10-05 · 1 Cardiovascular PhysiologyCardiovascular Physiology Cardiovascular

Cardiovascular PhysiologyCardiovascular Physiologyuserhome.brooklyn.cuny.edu/jsiegler/Lecture 10... · 2005-10-05 · 1 Cardiovascular PhysiologyCardiovascular Physiology Cardiovascular

Icosapent Ethyl Provides Consistent Cardiovascular Benefit in …/media/Clinical/PDF-Files/Approved-PDFs/2020… · 15/05/2020  · composite of CV death, nonfatal MI, nonfatal stroke,

Icosapent Ethyl Provides Consistent Cardiovascular Benefit in …/media/Clinical/PDF-Files/Approved-PDFs/2020… · 15/05/2020  · composite of CV death, nonfatal MI, nonfatal stroke,

The Cardiovascular System & Cardiovascular Emergencies.

The Cardiovascular System & Cardiovascular Emergencies.

Reduction of Cardiovascular Events with Icosapent … · 2020. 2. 27. · 2/27/2020 2 REDUCE-IT Design Adapted with permission ǂfrom Bhatt DL, Steg PG, Brinton EA, et al; on behalf

Reduction of Cardiovascular Events with Icosapent … · 2020. 2. 27. · 2/27/2020 2 REDUCE-IT Design Adapted with permission ǂfrom Bhatt DL, Steg PG, Brinton EA, et al; on behalf

Open Access Research Cardiovascular and non-cardiovascular ... · Cardiovascular and non-cardiovascular hospital admissions associated with atrial fibrillation: a Danish nationwide,

Open Access Research Cardiovascular and non-cardiovascular ... · Cardiovascular and non-cardiovascular hospital admissions associated with atrial fibrillation: a Danish nationwide,

Vascepa Exclusivity Determination by FDA

Vascepa Exclusivity Determination by FDA

Cardiovascular System. The Cardiovascular System Functions of the Cardiovascular System: Cardiovascular System Components:

Cardiovascular System. The Cardiovascular System Functions of the Cardiovascular System: Cardiovascular System Components: